What Comes After GLP-1 Success with Ken Fujioka
About this episode
The episode discusses the implications of GLP-1 medications in obesity treatment with Dr. Ken Fujioka.
What if the medications changing everything about obesity treatment are also creating problems nobody saw coming? We’re living through a genuine before-and-after moment in obesity medicine. Drugs that once seemed like science fiction are now producing 20, even 25% weight loss in real patients. But the questions piling up are just as staggering as the results: What happens to your muscle? Your bone? Your sense of self? And what happens when the medication stops? Holly and Jim sit down with Dr. Ken Fujioka, an endocrinologist, director of the Nutrition and Metabolic Research Center at Scripps Clinic, and one of the very first physicians to build an entire career around treating obesity, long before it was popular or even respected. He’s run over 100 clinical trials, treated thousands of patients a month, and watched this field go from Fen-phen clinics to GLP-1 breakthroughs. If anyone has the perspective to separate the genuine revolution from the hype, it’s Ken. This episode is a masterclass in what actually happens in the exam room, not in a clinical trial, not in a headline, but with real patients facing real tradeoffs. Ken is refreshingly practical, deeply experienced, and not…
More episodes of Weight Loss And ...
- Why Dietitians Matter More Than Ever with Maha Tahiri
- What the Nutrition Guidelines Still Haven't Caught Up To with Arne Astrup
- It Worked for Them. Will It Work for You? How to Actually Use Anecdotes
Explore listener stats, chart rankings, contacts and more on the Weight Loss And ... podcast page.